Found vs Sequence 2026: GLP-1 Weight Loss Programs Compared

Found vs Sequence vs Trimi: Full Comparison Table

Pricing Breakdown: What You Actually Pay

Pricing is where the Found versus Sequence difference becomes most concrete. Found charges one plan price per 28-day cycle that includes the compounded medication: on cash pay, $169 to $289 for semaglutide and $239 to $359 for tirzepatide; on its insurance track, $99 to $199 for semaglutide plus a video-visit copay. Found states that its price is the same at every dose, so titrating to a therapeutic dose does not raise the bill; what sets the price is the plan length you choose, with month to month costing the most per 28-day cycle.

WeightWatchers Clinic, which Sequence became, splits the bill in two. The membership costs $25 for the first month, then $74 a month on a 12-month plan or $84 a month on a 6-month plan, and those plans auto-renew for another term. GLP-1 medication is not included: the Care Team works with your commercial insurance to get it covered, and WeightWatchers also lists cash-pay options for brand-name medications. Your total therefore depends mostly on your coverage, not the membership fee.

The critical point is that the two platforms now prescribe different kinds of medication: compounded preparations at Found, FDA-approved brand-name products at WeightWatchers Clinic. Trimi offers compounded semaglutide at $99 per month and tirzepatide at $125 per month on its annual plan (a 12-month commitment), flat pricing that does not increase with dose escalation, with no membership fee. Over a 12-month treatment course on semaglutide, Found's 12-month cash plan totals $2,028 or more and Trimi's annual plan totals $1,188.

Medications: How the Three Programs Compare

Found and Trimi prescribe compounded semaglutide and tirzepatide, the two GLP-1 receptor agonists with the strongest clinical evidence for weight loss. WeightWatchers Clinic says it prescribes only FDA-approved medications, and WeightWatchers says it no longer offers access to compounded semaglutide, so patients there receive brand-name products billed separately from the membership.

Semaglutide, the active ingredient in branded Wegovy, works by mimicking the GLP-1 hormone to reduce appetite, slow gastric emptying, and improve satiety signaling. The landmark STEP 1 trial demonstrated 14.9 percent mean body weight loss over 68 weeks in adults with obesity (Wilding et al., New England Journal of Medicine, 2021). Those results were achieved with the FDA-approved product at 2.4 mg weekly; Found titrates patients toward a comparable dose range using compounded preparations, which have not been studied in their own trials.

Tirzepatide, the active ingredient in branded Zepbound, is a dual GIP/GLP-1 receptor agonist that targets two incretin pathways simultaneously. The SURMOUNT-1 trial demonstrated up to 22.5 percent mean body weight loss at the highest dose over 72 weeks (Jastreboff et al., New England Journal of Medicine, 2022). Tirzepatide is the more potent of the two medications. Found offers compounded tirzepatide at $239 to $359 per 28-day cycle on cash pay; WeightWatchers Clinic prescribes the brand-name product, billed separately. Trimi offers compounded tirzepatide at $125 per month on its annual plan.

Compounded preparations are made by state-licensed pharmacies against an individual prescription and are not FDA-approved as drugs; brand-name products are FDA-approved. That is the real medication difference between these programs, more than which platform writes the prescription.

Found: Mid-Range Pricing With Behavioral Coaching

Found differentiates itself through behavioral coaching that runs alongside GLP-1 medication. Their app includes habit-tracking tools, meal guidance, community forums, and access to coaching teams who help patients work through the behavioral and emotional dimensions of weight loss. This is a genuine value-add for patients who struggle with emotional eating, inconsistent habits, or lack of accountability.

The limitation of Found's coaching model is that not every patient uses it. Industry data consistently shows that engagement with digital health tools drops significantly after the first 60 to 90 days. If you stop using Found's coaching features but continue paying $169 to $289 per 28-day cycle for medication alone, you are effectively paying a premium for services you are not consuming. Found's side effect management is handled through their provider team, which is competent but may involve different providers across visits rather than a single dedicated clinician.

Sequence, Now WeightWatchers Clinic: Membership Plus Brand-Name Medication

Sequence became WeightWatchers Clinic, and joinsequence.com now redirects to WeightWatchers' weight-loss medication program (WW Med+). The model centers on a Care Team that includes clinicians and insurance specialists. On the medication side, the Care Team's main job is getting FDA-approved brand-name GLP-1s covered by commercial insurance, since the medication is billed separately from the membership.

The trade-off is that the membership fee is only part of the cost. Medication is billed on top, and the insurance coordinators work only with commercial plans, so for patients without commercial coverage for a brand-name GLP-1 the total can be far higher than the membership alone. Side effect management at WeightWatchers Clinic runs through the same Care Team.

Coaching and Support: Different Models, Different Values

The Found versus Sequence coaching comparison reveals fundamentally different philosophies. Found invests in behavioral tools, the app, the habit tracker, the community features, the coaching team. Their approach says: weight loss requires behavior change alongside medication, and technology can deliver that behavior change at scale. WeightWatchers Clinic pairs a Care Team with its GLP-1 Success Program, a behavior program included in every membership. Its approach says: get the right FDA-approved medication covered, then support it with an established behavior program.

Both philosophies have merit. Research supports that behavioral interventions improve weight loss outcomes when combined with pharmacotherapy (Wadden et al., NEJM, 2024). Patients who receive structured behavioral support alongside GLP-1 medication tend to lose modestly more weight and maintain it longer than those receiving medication alone. However, the incremental benefit of structured coaching varies widely between individuals. Self-motivated patients with existing healthy habits may see minimal additional benefit from coaching, while patients struggling with emotional eating or poor food relationships may find it transformative.

Found does not offer the combination of clinical focus and cost efficiency that characterizes Trimi's model. Trimi provides licensed provider oversight, dose management, and side effect support at $99 per month for semaglutide on its annual plan, at least $70 less per billing period than Found's lowest cash rate, which patients can put toward independent coaching, nutrition counseling, gym memberships, or healthier food choices if they want behavioral support beyond what their provider offers.

Where Both Found and Sequence Fall Short

Clinical Evidence: What the Trials Actually Show

When evaluating Found versus Sequence, it is essential to ground the comparison in clinical evidence rather than marketing claims. The weight loss results patients achieve are primarily driven by the medication, not the platform. Found prescribes compounded preparations; WeightWatchers Clinic prescribes FDA-approved brand-name products.

The STEP 1 trial enrolled 1,961 adults with BMI of 30 or greater (or 27 or greater with at least one weight-related comorbidity) and randomized them to semaglutide 2.4 mg weekly or placebo. At 68 weeks, the semaglutide group achieved a mean body weight reduction of 14.9 percent compared to 2.4 percent for placebo (Wilding et al., New England Journal of Medicine, 2021). Approximately one-third of participants lost 20 percent or more of their body weight. These results come from the FDA-approved product; compounded preparations have not been studied in their own trials.

The SURMOUNT-1 trial evaluated tirzepatide across three dose levels (5 mg, 10 mg, and 15 mg) in 2,539 adults with obesity. At 72 weeks, mean body weight reductions were 15.0 percent (5 mg), 19.5 percent (10 mg), and 20.9 percent (15 mg), with the highest responders achieving up to 22.5 percent body weight loss (Jastreboff et al., New England Journal of Medicine, 2022). These results were also achieved with the FDA-approved product. Found prescribes compounded tirzepatide ($239 to $359 per 28-day cycle on cash pay), which has not been studied in its own trials; WeightWatchers Clinic prescribes the FDA-approved product.

Neither Found nor Sequence has published independent clinical outcomes data demonstrating that their specific platform produces superior results to other providers prescribing the same medications. The landmark trials studied the FDA-approved brand products, not any telehealth platform's coaching model and not compounded preparations, which have not been studied in their own clinical trials.

Why Trimi Offers Better Value Than Found

For patients who have compared Found and Sequence and want compounded medication at a lower price than Found, Trimi provides a direct alternative: compounded semaglutide and tirzepatide from BelieveRx, a state-licensed 503A pharmacy. The clinical oversight is provider-guided with dose management and side effect support. What is different is the price and the commitment structure.

The Bottom Line: Found vs Sequence vs Trimi

Found is the right choice for patients who want behavioral coaching tools bundled with their GLP-1 prescription at a moderate price point. If app-based habit tracking, meal guidance, and community support are features you will actively use throughout your treatment, Found's $169 to $289 per 28-day cycle for semaglutide on cash pay, or its insurance track, represents reasonable value for the combined offering. Review our full Found review for a deeper analysis.

Sequence, now WeightWatchers Clinic, is the right choice for patients with commercial insurance that covers a brand-name GLP-1, or who specifically want an FDA-approved product with a Care Team to handle coverage. Its membership is $74 a month on a 12-month plan after a $25 first month, with medication billed separately. Read our full Sequence review for more details.

For the majority of patients, those who want effective GLP-1 medication, competent clinical oversight, and a price that makes long-term treatment sustainable, Trimi at $99 per month on the annual plan offers the strongest value proposition for compounded medication. Provider support is included, there is no membership fee, and saving $840 or more a year compared with Found's 12-month cash plan is better directed toward your overall health and wellbeing. Explore the cheapest GLP-1 options in 2026 for additional cost comparisons across the market.